Company / Operating Income per Share
Matinas BioPharma Holdings, Inc. Operating Income per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$5.66
FY2024
5-year range
-$5.66 / -$0.11
FY2020-FY2024
Trend
-4900.6%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income per Share changed -4901% YoY in FY2024, a notable deviation from the 9-year average annual change of -537%.
Based on SEC 10-K filings.
-5.66 in FY2024.
Declined from $-0.11 to $-5.66 over the past 2 years.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, operating income per share decreased 4900.6% year-over-year.
- Peak operating income per share was recorded in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -18.50 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$5.66 | -4900.6% |
| FY2023 | -$0.11 | +1.0% |
| FY2022 | -$0.11 | +7.5% |
| FY2021 | -$0.12 | +16.7% |
| FY2020 | -$0.15 | -14.8% |
| FY2019 | -$0.13 | +26.8% |
| FY2018 | -$0.18 | -3.7% |
| FY2017 | -$0.17 | -18.0% |
| FY2016 | -$0.14 | +53.0% |
| FY2015 | -$0.31 | - |
As of FY2024 · SEC 10-K · Updated Jun 24, 2026